SUMMARYIncreased serum levels of interferon-c (IFN-c) have been observed in acute graft-versus-host disease (GVHD). Recent in vitro studies have demonstrated that interleukin-12 (IL-12) and interleukin-18 (IL-18) synergistically up-regulate IFN-c secretion. In this communication, we investigated the factors relevant to IFN-c secretion in acute GVHD. A murine model of acute GVHD was established by injecting donor spleen cells into severe combined immunode®ciency (SCID) mice. A series of specimens, including sera, livers and spleens derived from the GVHD mice, were investigated with histological examination, enzyme-linked immunosorbent assay (ELISA),¯ow cytometry, and semiquantitative reverse transcription±polymerase chain reaction (RT±PCR). IFNc secretion increased in serum 3 days after spleen cell transfer, peaked on day 7, and then gradually decreased close to the baseline level by day 35. A synchronized increase of activated T cells and mRNA expression of IL-12, IL-18 and their respective receptors was observed after spleen cell transfer. However, only the kinetic expression pattern of IL-12 receptor (IL-12R) b2 chains was closely correlated with that of IFN-c, while IL-12 dropped to the baseline level earlier than IFN-c. Therefore, IFN-c expression in the early phase of acute GVHD is a mono-peak and self-restricted pattern. Its secretion is closely related with T-cell activation, the presence of IL-12, IL-18 and their respective receptors. However, the limiting factors for IFN-c secretion seem to be IL-12 and IL-12R b2 chains.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.